Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1635 watching

Investor Insights

Jun 6, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.

Consensus

Hold

Valuation

Fair Value

Similar

GWO

TOP PICK

This is a stock that no longer seems to get any respect, yet over the last 2 years, management have done a great deal to de-risk the company, hedge the exposure to interest rates and equity markets. Have also redesigned a lot of their product mix, which makes him less risky than a lot of their previous products. Continuing to expand on a global basis.

Wealthica Track your Stocks in your Watch List

SELL

(Market Call Minute) Business model will not come back strong any time soon.

BUY ON WEAKNESS

Don’t consider selling it. Didn’t like the preferred issue recently. Pays a good dividend. A Company he is watching quite closely. Longer term MFC could do well, but he would like to see it cheaper.

SHORT

Right now it looks like a Short as it has broken through a support level.

HOLD

If the current rally continues, this company will more than fully participate. Wouldn't commit new money to it but would continue to hold it. Prefers the Canadian banks against the lifecos.

DON'T BUY

Doesn't like this stock. Earnings are going the wrong way.

DON'T BUY

As being a tough performer. Insurance companies are having a hard time. There are 2 things to look at. 1) Do they have growth in their product sales? This company has had some challenges. 2) How do they do on their equity portfolios? The equity market has been wildly volatile. He would steer clear of insurance companies.

SELL

In a RRIF account. Should he sell? They continued to guide lower on the reserves that they need to come up with. Very large business in China and India. Don't let registered stocks influence whether you sell or not.

Wealthica Track your Stocks in your Watch List

HOLD

Management, over the last few years, has taken great strides in de-risking this company. Sensitivity to equity markets and interest rates is a lot less than what it was in 2008. Has also built up their capital.

DON'T BUY

Hit a 52 week low today. Earnings expectations are declining on this and other insurance companies. Below the 52 week average.

DON'T BUY

Doesn't own any of the insurance companies. They fund their liabilities through their investments. With equity markets being volatile and interest rates low, results have been pretty bad. These are a leveraged bet on the capital market. You are better off with banks because you at least get better dividends and more safety.

DON'T BUY

Insurance company invests life-premiums into bonds. Long bond yields are at record lows making it very difficult for them to make money on their portfolios. This copy is selling more life insurance in Asia and have mostly hedged their exposure to the stock market but difficult to see any buoyant prospects for insurance companies when the bond yields are so low.

DON'T BUY

Had a breakdown in 2008 and has been in a downtrend for the past 3 years. Has formed any kind of a base yet.

WEAK BUY

Was a 2% position but now is less. Underlying business is fine and growing well. The necessity of marking the market because bond prices are low is the problem. 4-5% downside risk both here and in the states. He would buy it here if you want something in this space.

PAST TOP PICK

(A Top Pick Sept 30/10. Up 5.91%.) Still likes.

Showing 1,246 to 1,260 of 2,279 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)